These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1138664)

  • 1. Bretylium Tosylate; adverse effects in acute myocardial infarction.
    Luomanmaäki K; Heikkilä J; Härtel G
    Arch Intern Med; 1975 Apr; 135(4):515-8. PubMed ID: 1138664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
    Lucchesi BR; Kniffen FJ
    Circulation; 1975 Dec; 52(6 Suppl):III241-7. PubMed ID: 1182977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of bretylium tosylate in the prevention of the rhythm disorders of myocardial infarct].
    Torresani J; Lévy P; Jausseran JM; Chevalier D; Lévy S; Heuillet G; Fondarai J; Jouve A
    Arch Mal Coeur Vaiss; 1971 Jul; 64(7):1033-54. PubMed ID: 5000806
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):530-43. PubMed ID: 5650734
    [No Abstract]   [Full Text] [Related]  

  • 8. Bretylium tosylate--induced stabilization of electrical systole duration in patients with acute myocardial infarction.
    Jouve R; Puddu PE; Torresani J
    Heart Lung; 1982; 11(5):399-405. PubMed ID: 6921188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction.
    Taylor SH; Saxton C; Davies PS; Stoker JB
    Br Heart J; 1970 May; 32(3):326-9. PubMed ID: 4911756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic effects of xylocaine and ajmaline in myocardial infarction].
    Bernard R; Lewinson H; Renta C; Thys JP
    Arch Mal Coeur Vaiss; 1972 Oct; 65(10):1215-8. PubMed ID: 4632665
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental and clinical effects of bretylium tosylate on ventricular fibrillation, arrhythmias, and heart block.
    Bacaner M
    Geriatrics; 1971 Jan; 26(1):132-48. PubMed ID: 5539447
    [No Abstract]   [Full Text] [Related]  

  • 15. Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction.
    Terry G; Vellani CW; Higgins MR; Doig A
    Br Heart J; 1970 Jan; 32(1):21-5. PubMed ID: 5417842
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ineffective use of lidocaine in preventing reperfusion arrhythmias in patients with acute myocardial infarct].
    Kuck KH; Jannasch B; Schlüter M; Schofer J; Mathey DG
    Z Kardiol; 1985 Mar; 74(3):185-90. PubMed ID: 3158128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias.
    Kron IL; Nolan SP
    Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.